156 related articles for article (PubMed ID: 29281181)
1. The Cumulative Daily Tolerance Levels of Potentially Toxic Excipients Ethanol and Propylene Glycol Are Commonly Exceeded in Neonates and Infants.
Valeur KS; Hertel SA; Lundstrøm KE; Holst H
Basic Clin Pharmacol Toxicol; 2018 May; 122(5):523-530. PubMed ID: 29281181
[TBL] [Abstract][Full Text] [Related]
2. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates.
Shehab N; Lewis CL; Streetman DD; Donn SM
Pediatr Crit Care Med; 2009 Mar; 10(2):256-9. PubMed ID: 19188870
[TBL] [Abstract][Full Text] [Related]
3. Excipient exposure in very low birth weight preterm neonates.
Akinmboni TO; Davis NL; Falck AJ; Bearer CF; Mooney SM
J Perinatol; 2018 Feb; 38(2):169-174. PubMed ID: 29095430
[TBL] [Abstract][Full Text] [Related]
4. Safe excipient exposure in neonates and small children - protocol for the SEEN project.
Valeur KS; Hertel SA; Lundstrøm KE; Holst H
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157063
[TBL] [Abstract][Full Text] [Related]
5. Possible effects of excipients used in the parenteral drugs administered in critically ill adults, children, and neonates.
Sridharan K; Hasan HM; Al Jufairi M; Al Daylami A; Al Ansari E; Qader AM; Pasha SAA
Expert Opin Drug Saf; 2020 Dec; 19(12):1625-1640. PubMed ID: 32767900
[TBL] [Abstract][Full Text] [Related]
6. Potentially harmful excipients in neonatal medicines: a pan-European observational study.
Nellis G; Metsvaht T; Varendi H; Toompere K; Lass J; Mesek I; Nunn AJ; Turner MA; Lutsar I;
Arch Dis Child; 2015 Jul; 100(7):694-9. PubMed ID: 25854872
[TBL] [Abstract][Full Text] [Related]
7. Harmful excipients in medicines for neonates in Spain.
Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ
Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405
[TBL] [Abstract][Full Text] [Related]
8. The propylene glycol research project to illustrate the feasibility and difficulties to study toxicokinetics in neonates.
Kulo A; de Hoon JN; Allegaert K
Int J Pharm; 2012 Oct; 435(2):112-4. PubMed ID: 22641171
[TBL] [Abstract][Full Text] [Related]
9. Safety of "inert" additives or excipients in paediatric medicines.
Nahata MC
Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F392-3. PubMed ID: 19846397
[No Abstract] [Full Text] [Related]
10. Propylene glycol: an often unrecognized cause of allergic contact dermatitis in patients using topical corticosteroids.
Al Jasser M; Mebuke N; de Gannes GC
Skin Therapy Lett; 2011 May; 16(5):5-7. PubMed ID: 21611683
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Investigation on Exposure to Potentially Harmful Excipients by Injection Drug Administration in Children Under 2 Years of Age and Analysis of Association with Adverse Events: A Single-Center, Retrospective Observational Study.
Saito J; Nakamura H; Akabane M; Yamatani A
Ther Innov Regul Sci; 2024 Mar; 58(2):316-335. PubMed ID: 38055156
[TBL] [Abstract][Full Text] [Related]
12. Toxic additives in medication for preterm infants.
Whittaker A; Currie AE; Turner MA; Field DJ; Mulla H; Pandya HC
Arch Dis Child Fetal Neonatal Ed; 2009 Jul; 94(4):F236-40. PubMed ID: 19158148
[TBL] [Abstract][Full Text] [Related]
13. Potentially harmful excipients in neonatal medications: a multicenter nationwide observational study in Japan.
Saito J; Nadatani N; Setoguchi M; Nakao M; Kimura H; Sameshima M; Kobayashi K; Matsumoto H; Yoshikawa N; Yokoyama T; Takahashi H; Suenaga M; Watanabe R; Imai K; Obara M; Hashimoto M; Yamamoto K; Fujiwara N; Sakata W; Nagai H; Enokihara T; Katayama S; Takahashi Y; Araki M; Iino K; Akiyama N; Katsu H; Fushimi K; Takeda T; Torimoto M; Kishi R; Mitsuya N; Kihara R; Hasegawa Y; Hamada Y; Kimura T; Wada M; Tanzawa A; Yamatani A
J Pharm Health Care Sci; 2021 Jul; 7(1):23. PubMed ID: 34193299
[TBL] [Abstract][Full Text] [Related]
14. Spectroscopic detection of brain propylene glycol in neonates: Effects of different pharmaceutical formulations of phenobarbital.
Pouwels PJW; van de Lagemaat M; van de Pol LA; Witjes BCM; Zonnenberg IA
J Magn Reson Imaging; 2019 Apr; 49(4):1062-1068. PubMed ID: 30350475
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical excipients with potential to cause adverse effects in paediatric nasal medicines.
Stjepanovic AN; Todorovic NB; Tesic TZ; Komazec ZS; Canji-Panic JM; Lalic-Popovic MN
Regul Toxicol Pharmacol; 2022 Aug; 133():105225. PubMed ID: 35817211
[TBL] [Abstract][Full Text] [Related]
16. Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates.
Nellis G; Metsvaht T; Varendi H; Lass J; Duncan J; Nunn AJ; Turner MA; Lutsar I
Paediatr Drugs; 2016 Jun; 18(3):221-30. PubMed ID: 27099961
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical Excipient Exposure in a Neonatal Intensive Care Unit.
Nasrollahi S; Meera NK; Boregowda S
Indian Pediatr; 2020 Sep; 57(9):801-804. PubMed ID: 32999107
[TBL] [Abstract][Full Text] [Related]
18. Prospective assessment of short-term propylene glycol tolerance in neonates.
Allegaert K; Vanhaesebrouck S; Kulo A; Cosaert K; Verbesselt R; Debeer A; de Hoon J
Arch Dis Child; 2010 Dec; 95(12):1054-8. PubMed ID: 20959360
[TBL] [Abstract][Full Text] [Related]
19. Safety issues with ethanol as an excipient in drugs intended for pediatric use.
Zuccotti GV; Fabiano V
Expert Opin Drug Saf; 2011 Jul; 10(4):499-502. PubMed ID: 21417862
[TBL] [Abstract][Full Text] [Related]
20. Solvent-based formulations for intravenous mouse pharmacokinetic studies: tolerability and recommended solvent dose limits.
Thackaberry EA; Wang X; Schweiger M; Messick K; Valle N; Dean B; Sambrone A; Bowman T; Xie M
Xenobiotica; 2014 Mar; 44(3):235-41. PubMed ID: 24138296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
